Tal Zaks’s Israeli startup targets rare genetic diseases Posted by NOWlej | Jan 28, 2025 | Israel NOWlej | 0 | The former Moderna CMO, who led development of the company’s Covid vaccine, tells “Globes” about Averna Therapeutics, which through gene editing is developing groundbreaking drugs. Read More Start ups . Read More in Israel NOWlej.